Effect of Abidol Combined with Oseltamivir on Fever in Patients with In-fluenza
Objective To explore the improvement effect of abidol combined with oseltamivir on influenza.Methods The clinical data of 82 patients with influenza admitted to Fuzhou First General Hospital Affiliated to Fujian Medical University from July 2022 to June 2023 were retrospectively selected.According to different treatment methods,they were divided into control group(n=41)and study group(n=41).The control group was treated with abidol,and the study group was treated with abidol combined with oseltamivir.The total effective rate,adverse reactions,serum in-flammatory factor levels and symptom scores of the two groups before and after treatment were compared.Results The total effective rate of the study group was 97.56%,which was higher than 82.93% of the control group,and the differ-ence was statistically significant(χ2=4.987,P=0.026).The total incidence of adverse reactions in the study group and the control group was 4.88% and 2.44%,respectively,and the difference was not statistically significant(χ2=0.346,P=0.556).After treatment,the serum C-reactive protein,interleukin-6 and procalcitonin in the study group were lower than those in the control group,and the differences were statistically significant(all P<0.001).After treatment,the scores of fever,cough and fatigue in the study group were lower than those in the control group,and the differences were statistically significant(all P<0.001).Conclusion In the treatment of influenza patients,the combination of abi-dol and oseltamivir can enhance clinical efficacy,promote effective relief of symptoms,reduce inflammation,with good safety.
NETL
NSTL
万方数据
